New CT Imaging Protocols Improve Liver Lesion Diagnoses
By MedImaging International staff writers Posted on 03 Jan 2017 |

Image: A Spectral Photon Counting CT (SPCCT) scanner in use (Photo courtesy of US NIH).
Researchers in Germany have shown that new dual-contrast Computed Tomography (CT) imaging protocols can improve the diagnosis of liver diseases while at the same time reducing radiation dose.
In the new technique the researchers simultaneously administered an iodine contrast agent for the arterial phase, and a gadolinium agent for the venous phase of the liver, and then used a modality called Spectral Photon Counting CT (SPCCT) to simultaneously assess the agent enhancement in the liver in various contrast phases.
The new technique was presented at the annual Radiological Society of North America (RSNA 2016) meeting by researchers from the Technical University Munich (Munich, Germany). The new protocols could enable clinicians to differentiate hemangioma and other liver abnormalities from Hepato-Cellular Carcinoma (HCC), for example, and spare patients with only small benign liver lesions, from undergoing unnecessary and expensive procedures.
The Results showed that by using SPCCT and an optimized contrast injection protocol, it was possible to provide contrast-enhanced images in a single CT scan, reducing radiation dose. The scan showed both arterial gadolinium distribution, and the portal-venous phase of iodine. The liver lesions, as well as the arterial and portal-venous contrast enhancement patterns were also visible in the scan. According to the researchers, the new technique eliminates mistaken registration of artifacts between acquisitions.
Daniela Muenzel, MD, Laboratory for Advanced Computed Tomography Imaging, Technical University of Munich, said, "This multi-phase visualization of the liver at one time point by a single CT scan exhibits perfect co-registration of the images in different phases, allowing for more accurate and quantitative subsequent voxel-by-voxel post processing and a significant reduction in radiation dose. By using two contrast agents and different uptake characteristics in liver lesions, we can classify cysts, hemangiomas, HCC and metastases in a single CT scan.
Related Links:
Technical University Munich
In the new technique the researchers simultaneously administered an iodine contrast agent for the arterial phase, and a gadolinium agent for the venous phase of the liver, and then used a modality called Spectral Photon Counting CT (SPCCT) to simultaneously assess the agent enhancement in the liver in various contrast phases.
The new technique was presented at the annual Radiological Society of North America (RSNA 2016) meeting by researchers from the Technical University Munich (Munich, Germany). The new protocols could enable clinicians to differentiate hemangioma and other liver abnormalities from Hepato-Cellular Carcinoma (HCC), for example, and spare patients with only small benign liver lesions, from undergoing unnecessary and expensive procedures.
The Results showed that by using SPCCT and an optimized contrast injection protocol, it was possible to provide contrast-enhanced images in a single CT scan, reducing radiation dose. The scan showed both arterial gadolinium distribution, and the portal-venous phase of iodine. The liver lesions, as well as the arterial and portal-venous contrast enhancement patterns were also visible in the scan. According to the researchers, the new technique eliminates mistaken registration of artifacts between acquisitions.
Daniela Muenzel, MD, Laboratory for Advanced Computed Tomography Imaging, Technical University of Munich, said, "This multi-phase visualization of the liver at one time point by a single CT scan exhibits perfect co-registration of the images in different phases, allowing for more accurate and quantitative subsequent voxel-by-voxel post processing and a significant reduction in radiation dose. By using two contrast agents and different uptake characteristics in liver lesions, we can classify cysts, hemangiomas, HCC and metastases in a single CT scan.
Related Links:
Technical University Munich
Latest Radiography News
- World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
- AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
- Higher Chest X-Ray Usage Catches Lung Cancer Earlier and Improves Survival
- AI-Powered Mammograms Predict Cardiovascular Risk
- Generative AI Model Significantly Reduces Chest X-Ray Reading Time
- AI-Powered Mammography Screening Boosts Cancer Detection in Single-Reader Settings
- Photon Counting Detectors Promise Fast Color X-Ray Images
- AI Can Flag Mammograms for Supplemental MRI
- 3D CT Imaging from Single X-Ray Projection Reduces Radiation Exposure
- AI Method Accurately Predicts Breast Cancer Risk by Analyzing Multiple Mammograms
- Printable Organic X-Ray Sensors Could Transform Treatment for Cancer Patients
- Highly Sensitive, Foldable Detector to Make X-Rays Safer
- Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram
- Artificial Intelligence Accurately Predicts Breast Cancer Years Before Diagnosis
- AI-Powered Chest X-Ray Detects Pulmonary Nodules Three Years Before Lung Cancer Symptoms
- AI Model Identifies Vertebral Compression Fractures in Chest Radiographs
Channels
MRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more